COPENHAGEN, Denmark, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransConTM technology to address significant unmet medical needs, today announced its support of `Children`s Growth Awareness Week ` taking place September 16-22, 2018, as a part of the company`s commitment to patients and to improving the lives of people with growth disorders. This initiative will be celebrated worldwide as `International Children`s Growth Awareness Day` on September 20, 2018. In July 2014, the U.S. Senate passed S. Res. 489, a resolution recognizing and supporting the goals and ideals of a `Growth Awareness Week,` to increase...
|
